Literature DB >> 20171506

Radiation dose-volume effects in radiation-induced rectal injury.

Jeff M Michalski1, Hiram Gay, Andrew Jackson, Susan L Tucker, Joseph O Deasy.   

Abstract

The available dose/volume/outcome data for rectal injury were reviewed. The volume of rectum receiving >or=60 Gy is consistently associated with the risk of Grade >or=2 rectal toxicity or rectal bleeding. Parameters for the Lyman-Kutcher-Burman normal tissue complication probability model from four clinical series are remarkably consistent, suggesting that high doses are predominant in determining the risk of toxicity. The best overall estimates (95% confidence interval) of the Lyman-Kutcher-Burman model parameters are n = 0.09 (0.04-0.14); m = 0.13 (0.10-0.17); and TD(50) = 76.9 (73.7-80.1) Gy. Most of the models of late radiation toxicity come from three-dimensional conformal radiotherapy dose-escalation studies of early-stage prostate cancer. It is possible that intensity-modulated radiotherapy or proton beam dose distributions require modification of these models because of the inherent differences in low and intermediate dose distributions. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171506      PMCID: PMC3319467          DOI: 10.1016/j.ijrobp.2009.03.078

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  34 in total

1.  Fitting of normal tissue tolerance data to an analytic function.

Authors:  C Burman; G J Kutcher; B Emami; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

2.  Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum.

Authors:  Massoud al-Abany; Asgeir R Helgason; Anna-Karin Agren Cronqvist; Bengt Lind; Panayiotis Mavroidis; Peter Wersäll; Helena Lind; Eva Qvanta; Gunnar Steineck
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

3.  Fractionation and late rectal toxicity.

Authors:  David J Brenner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

4.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

Authors:  J D Cox; J Stetz; T F Pajak
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

5.  Is there more than one late radiation proctitis syndrome?

Authors:  J W Denham; P C O'Brien; R H Dunstan; J Johansen; A See; C S Hamilton; S Bydder; S Wright
Journal:  Radiother Oncol       Date:  1999-04       Impact factor: 6.280

6.  Late GI and GU complications in the treatment of prostate cancer.

Authors:  T E Schultheiss; W R Lee; M A Hunt; A L Hanlon; R S Peter; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-01       Impact factor: 7.038

7.  Diabetes mellitus: a predictor for late radiation morbidity.

Authors:  D M Herold; A L Hanlon; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-02-01       Impact factor: 7.038

8.  Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.

Authors:  Tetsuo Akimoto; Hiroyuki Muramatsu; Mitsuhiro Takahashi; Jun-Ichi Saito; Yoshizumi Kitamoto; Koichi Harashima; Yasushi Miyazawa; Masami Yamada; Kazuto Ito; Kouhei Kurokawa; Hidetoshi Yamanaka; Takashi Nakano; Norio Mitsuhashi; Hideo Niibe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

9.  Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Authors:  Stephanie T H Peeters; Wilma D Heemsbergen; Wim L J van Putten; Annerie Slot; Hans Tabak; Jan Willem Mens; Joos V Lebesque; Peter C M Koper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

10.  The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

Authors:  M S Litwin; R D Hays; A Fink; P A Ganz; B Leake; R H Brook
Journal:  Med Care       Date:  1998-07       Impact factor: 2.983

View more
  202 in total

1.  Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning.

Authors:  T Long; M Matuszak; M Feng; B A Fraass; R K Ten Haken; H E Romeijn
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

2.  A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.

Authors:  Mitchell S Anscher; Michael G Chang; Drew Moghanaki; Mihaela Rosu; Ross B Mikkelsen; Diane Holdford; Vicki Skinner; Baruch M Grob; Arun Sanyal; Aiping Wang; Nitai D Mukhopadhyay
Journal:  Am J Clin Oncol       Date:  2018-06       Impact factor: 2.339

3.  Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.

Authors:  Yu Kuang; Lili Wu; Emily Hirata; Kyle Miyazaki; Miles Sato; Sandi A Kwee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

4.  Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.

Authors:  Justin E Bekelman; Nandita Mitra; Jason Efstathiou; Kaijun Liao; Robert Sunderland; Deborah N Yeboa; Katrina Armstrong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-16       Impact factor: 7.038

5.  A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma : Comparison of 3‑dimensional conformal radiotherapy, tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy.

Authors:  Sergiu Scobioala; Christopher Kittel; Philipp Niermann; Heidi Wolters; Katharina Helene Susek; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2018-05-31       Impact factor: 3.621

6.  CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm.

Authors:  Shayan Mostafaei; Hamid Abdollahi; Shiva Kazempour Dehkordi; Isaac Shiri; Abolfazl Razzaghdoust; Seyed Hamid Zoljalali Moghaddam; Afshin Saadipoor; Fereshteh Koosha; Susan Cheraghi; Seied Rabi Mahdavi
Journal:  Radiol Med       Date:  2019-09-24       Impact factor: 3.469

Review 7.  Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: new clinical trial designs should be considered.

Authors:  Timothy N Showalter; Nolan A Wages; Nitin Ohri
Journal:  Cancer Biol Ther       Date:  2014-02-04       Impact factor: 4.742

8.  Influence of image slice thickness on rectal dose-response relationships following radiotherapy of prostate cancer.

Authors:  C Olsson; M Thor; M Liu; V Moissenko; S E Petersen; M Høyer; A Apte; J O Deasy
Journal:  Phys Med Biol       Date:  2014-06-17       Impact factor: 3.609

9.  Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.

Authors:  Kentaro Ishii; Ryo Ogino; Yukinari Hosokawa; Chiaki Fujioka; Wataru Okada; Ryota Nakahara; Ryu Kawamorita; Takuhito Tada; Yoshiki Hayashi; Toshifumi Nakajima
Journal:  Br J Radiol       Date:  2016-03-31       Impact factor: 3.039

10.  An observational trial to establish the effect of hyperbaric oxygen treatment on pelvic late radiation tissue injury due to radiotherapy.

Authors:  James Andren; Michael H Bennett
Journal:  Diving Hyperb Med       Date:  2020-09-30       Impact factor: 0.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.